Analyte monitoring device and methods of use

Details for Australian Patent Application No. 2010266535 (hide)

Owner Abbott Diabetes Care Inc.

Inventors Heller, Adam; Feldman, Benjamin Jay; Karinka, Shridhara Alva; Wang, Yi; Galasso, John R.

Agent Freehills

Pub. Number AU-A-2010266535

PCT Pub. Number WO2011/002694

Priority 12/495,807 30.06.09 US

Filing date 26 June 2010

Wipo publication date 6 January 2011

International Classifications

A61B 5/1468 (2006.01) Measuring for diagnostic purposes

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2011/002694 Priority application(s): WO2011/002694

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010266537-Trans4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phen yl]methyl] (2-methyl-2H-tetrazol-5-yl) amino]-2,3,4,5-tetrahydro-7,9-dimethyl1H-1-benzazepin-1-yl]methyl]-cyclohex anecarboxylic acid

2010266534-Analyte monitoring device and methods of use